NUR 2474 Pharmacology Exam 2 Review: Q’s And A’s
Spironolactone (Aldactone) Right Ans - Not indicated for pulmonary
edema, a potassium-sparing diuretic.
Digoxin Right Ans - Used for congestive heart failure, can cause fatal
dysrhythmias especially with low potassium levels.
Potassium level of 3.5 mEq/L Right Ans - Low potassium level that can
trigger fatal dysrhythmias, especially in patients taking Digoxin.
Potassium level of 6 mEq/L Right Ans - High potassium level indicating
hyperkalemia, contraindicating Spironolactone use.
ACE inhibitor captopril (Capoten) with Spironolactone Right Ans - Should
not be administered together due to potential elevation of potassium levels.
Bumetanide (Bumex) Right Ans - A potassium-wasting diuretic appropriate
for patients with hyperkalemia.
Furosemide (Lasix) Right Ans - A potent diuretic used for rapid or massive
mobilization of fluids, indicated for congestive heart failure with respiratory
distress and pulmonary edema.
Hydrochlorothiazide (HydroDIURIL) Right Ans - A diuretic less rapid than
Furosemide, not indicated for pulmonary edema.
Mannitol (Osmitrol) Right Ans - Indicated for patients with increased
intracranial pressure, must be discontinued if signs of pulmonary congestion
or heart failure occur.
Gentamicin (Garamycin) Right Ans - An ototoxic drug that, when taken
with Furosemide, can increase the risk of hearing loss.
Hydrochlorothiazide (HydroDIURIL) in older adults Right Ans - Should not
be given to patients with severe renal impairment.
Elevated creatinine clearance Right Ans - A concern when considering the
administration of Hydrochlorothiazide to patients.
, Thiazides Right Ans - May elevate serum glucose in diabetic patients.
LDL cholesterol Right Ans - Increased by thiazides, but not a risk if levels
are low.
Spironolactone Right Ans - Potassium-sparing diuretic to counteract
potassium-wasting effects.
Renal artery stenosis Right Ans - Concern with ACE inhibitors due to
potential severe renal insufficiency.
ACE inhibitor Right Ans - Can cause severe hypotension with the first dose.
Pathologic changes in the heart Right Ans - ACE inhibitors can prevent or
reverse these changes.
Ramipril Right Ans - Reduces the risk of stroke and heart attack.
Dry cough Right Ans - Common side effect of ACE inhibitors, may lead to
discontinuation.
Hyperkalemia Right Ans - Risk when taking spironolactone with potassium
supplements.
Dehydration Right Ans - Not increased risk with spironolactone due to its
weak diuretic effect.
Venous return to the heart Right Ans - ACE inhibitors reduce this,
improving cardiac output.
Diabetic nephropathy Right Ans - ACE inhibitors can delay onset in
patients with less advanced nephropathy.
Dry cough with ACE inhibitors Right Ans - Occurs in about 10% of patients,
common reason for discontinuation.
Major cardiovascular event Right Ans - Ramipril reduces the risk in
patients at high risk for this event.
Spironolactone (Aldactone) Right Ans - Not indicated for pulmonary
edema, a potassium-sparing diuretic.
Digoxin Right Ans - Used for congestive heart failure, can cause fatal
dysrhythmias especially with low potassium levels.
Potassium level of 3.5 mEq/L Right Ans - Low potassium level that can
trigger fatal dysrhythmias, especially in patients taking Digoxin.
Potassium level of 6 mEq/L Right Ans - High potassium level indicating
hyperkalemia, contraindicating Spironolactone use.
ACE inhibitor captopril (Capoten) with Spironolactone Right Ans - Should
not be administered together due to potential elevation of potassium levels.
Bumetanide (Bumex) Right Ans - A potassium-wasting diuretic appropriate
for patients with hyperkalemia.
Furosemide (Lasix) Right Ans - A potent diuretic used for rapid or massive
mobilization of fluids, indicated for congestive heart failure with respiratory
distress and pulmonary edema.
Hydrochlorothiazide (HydroDIURIL) Right Ans - A diuretic less rapid than
Furosemide, not indicated for pulmonary edema.
Mannitol (Osmitrol) Right Ans - Indicated for patients with increased
intracranial pressure, must be discontinued if signs of pulmonary congestion
or heart failure occur.
Gentamicin (Garamycin) Right Ans - An ototoxic drug that, when taken
with Furosemide, can increase the risk of hearing loss.
Hydrochlorothiazide (HydroDIURIL) in older adults Right Ans - Should not
be given to patients with severe renal impairment.
Elevated creatinine clearance Right Ans - A concern when considering the
administration of Hydrochlorothiazide to patients.
, Thiazides Right Ans - May elevate serum glucose in diabetic patients.
LDL cholesterol Right Ans - Increased by thiazides, but not a risk if levels
are low.
Spironolactone Right Ans - Potassium-sparing diuretic to counteract
potassium-wasting effects.
Renal artery stenosis Right Ans - Concern with ACE inhibitors due to
potential severe renal insufficiency.
ACE inhibitor Right Ans - Can cause severe hypotension with the first dose.
Pathologic changes in the heart Right Ans - ACE inhibitors can prevent or
reverse these changes.
Ramipril Right Ans - Reduces the risk of stroke and heart attack.
Dry cough Right Ans - Common side effect of ACE inhibitors, may lead to
discontinuation.
Hyperkalemia Right Ans - Risk when taking spironolactone with potassium
supplements.
Dehydration Right Ans - Not increased risk with spironolactone due to its
weak diuretic effect.
Venous return to the heart Right Ans - ACE inhibitors reduce this,
improving cardiac output.
Diabetic nephropathy Right Ans - ACE inhibitors can delay onset in
patients with less advanced nephropathy.
Dry cough with ACE inhibitors Right Ans - Occurs in about 10% of patients,
common reason for discontinuation.
Major cardiovascular event Right Ans - Ramipril reduces the risk in
patients at high risk for this event.
